Selectis Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.158875 million compared to USD 0.155071 million a year ago. Revenue was USD 9.58 million compared to USD 7.32 million a year ago. Net loss was USD 0.990925 million compared to USD 0.052992 million a year ago. Basic loss per share from continuing operations was USD 0.33 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.33 compared to USD 0.02 a year ago.
For the nine months, sales was USD 0.469938 million compared to USD 0.93336 million a year ago. Revenue was USD 29.8 million compared to USD 19.09 million a year ago. Net loss was USD 0.203623 million compared to USD 0.483716 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.18 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.18 a year ago.